HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 288/1/H83    most recent 00881.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Barrère-Lemaire, S. Articles by Piot, C. Search for Related Content PubMed PubMed Citation Articles by Barrère-Lemaire, S. Articles by Piot, C.

Morphine mimics the antiapoptotic effect of preconditioning via an Ins(1,4,5)P₃ signaling pathway in rat ventricular myocytes

Laboratoire de Génomique Fonctionnelle, Centre National de la Recherche Scientifique, Montpellier Cedex 5, France

Submitted 15 September 2003 ; accepted in final form 18 August 2004

Morphine has cardioprotective effects against ischemic-reperfusion injuries. This study investigates whether morphine could mimic the antiapoptotic effect of preconditioning using a model of cultured neonatal rat cardiomyocytes subjected to metabolic inhibition (MI). To quantify MI-induced apoptosis, DNA fragmentation and mitochondrial cytochrome c release levels were measured by ELISA. MI-dependent DNA fragmentation was prevented by both Z-VAD-fmk (20 µM), a pan-caspase inhibitor, and cyclosporine A (CsA; 5 µM), a mitochondrial pore transition blocker, added during MI (36% and 54% decrease, respectively). MI-dependent cytochrome c release was not blocked by Z-VAD-fmk but was decreased (38%) by CsA during MI. Metabolic preconditioning (MIP) and preconditioning with morphine (1 µM) were also assessed. MI-dependent DNA fragmentation and cytochrome c release were prevented by MIP (40% and 45% decrease, respectively) and morphine (34% and 45%, respectively). The antiapoptotic effect of morphine was abolished by naloxone (10 nM), a nonselective opioid receptor antagonist, or xestospongin C (XeC, 400 nM), an inhibitor of inositol (1,4,5)-trisphosphate [Ins(1,4,5)P₃]-mediated Ca²⁺ release. Ca²⁺ preconditioning, induced by increasing extracellular Ca²⁺ from 1.8 to 3.3 mM, mimicked the antiapoptotic effect of morphine on DNA fragmentation (24% decrease) and cytochrome c release (57% decrease). This effect mediated by extracellular Ca²⁺ was also abolished by XeC. Measurements of intracellular Ca²⁺ concentration using fura-2 microspectrofluorimetry showed that morphine induces Ins(1,4,5)P₃-dependent Ca²⁺ transients abolished by 2-aminoethoxydiphenyl borate (2-APB), a cell-permeable Ins(1,4,5)P₃ antagonist. These results suggest that morphine preconditioning prevents simulated ischemia-reperfusion-induced apoptosis via an Ins(1,4,5)P₃ signaling pathway in rat ventricular myocytes.

opioid; cardioprotection; calcium

This article has been cited by other articles:

				Yan Zhang, Qiuyue Chen, and L.-C. Yu Morphine: A Protective or Destructive Role in Neurons? Neuroscientist, December 1, 2008; 14(6): 561 - 570. [Abstract] [PDF]

				K. Przyklenk, M. Maynard, and P. Whittaker First molecular evidence that inositol trisphosphate signaling contributes to infarct size reduction with preconditioning Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H2008 - H2012. [Abstract] [Full Text] [PDF]

				K. Przyklenk, M. Maynard, and P. Whittaker Reduction of infarct size with D-myo-inositol trisphosphate: role of PI3-kinase and mitochondrial KATP channels Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H830 - H836. [Abstract] [Full Text] [PDF]

				D. Weihrauch, J. G. Krolikowski, M. Bienengraeber, J. R. Kersten, D. C. Warltier, and P. S. Pagel Morphine Enhances Isoflurane-Induced Postconditioning Against Myocardial Infarction: The Role of Phosphatidylinositol-3-Kinase and Opioid Receptors in Rabbits Anesth. Analg., October 1, 2005; 101(4): 942 - 949. [Abstract] [Full Text] [PDF]